openPR Logo
Press release

U.S. Opioid Withdrawal Treatment Market Emerging Trends and Growth Prospects 2034 |Indivior PLC,Alkermes plc,Teva Pharmaceutical Industries Ltd.

04-22-2025 01:33 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Opioid Withdrawal Treatment

Opioid Withdrawal Treatment

"The U.S. Opioid Withdrawal Treatment Market Size is projected to reach at a CAGR of 7.5% during 2025-2034."

U.S. Opioid Withdrawal Treatment market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the U.S. Opioid Withdrawal Treatment Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain, future strategies. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche U.S. Opioid Withdrawal Treatment are aligned with your aims.

This report is also available in the following languages : Japanese (米国のオピオイド離脱治療市場), Korean (미국 오피오이드 금단 치료 시장), Chinese (美国阿片类药物戒断治疗市场), French (Marché américain des traitements de sevrage aux opioïdes), German (US-Markt für Opioid-Entzugsbehandlungen), and Italian (Mercato statunitense dei trattamenti per l'astinenza da oppioidi), etc.

Request for a FREE sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/50606
(Exclusive Offer: We are offering discount of upto 40% on bundled report purchase. Maximum report count 2-4)

Market Overview:
The U.S. opioid withdrawal treatment market is expected to grow due to rising awareness of addiction and increased access to treatment options. Expanding use of medications like buprenorphine and lofexidine, coupled with behavioral therapies, is improving patient outcomes. Federal and state initiatives to combat the opioid crisis, including expanded Medicaid coverage and funding for treatment programs, support market growth. Telehealth integration and outpatient treatment centers are enhancing reach and continuity of care. Innovation in non-opioid withdrawal therapies and long-acting formulations offer additional growth potential in addressing this critical public health challenge.

Competitive Dashboard:
Indivior PLC,Alkermes plc,Teva Pharmaceutical Industries Ltd.,Mallinckrodt Pharmaceuticals,Pfizer Inc.,Purdue Pharma L.P.,Bracket Holdings,NRx Pharmaceuticals,Celgene Corporation,Gilead Sciences, Inc.,Horizon Therapeutics plc,Zogenix, Inc.,Sandoz (a Novartis division),Las Vegas Pain Institute,Voyager Therapeutics, Inc.

The U.S. Opioid Withdrawal Treatment Market report is generated through systematic data collection and analysis, including research on individuals, organizations, and social opinions. The U.S. Opioid Withdrawal Treatment Market is categorized based on type and application. Players, stakeholders, and other participants in the market can leverage this research as a valuable resource to gain a competitive edge. The segmental study focuses on production capacity, revenue, and forecasts by type and application for the years 2025-2034.

(Exclusive offer: Flat 20% discount on this report) Buy Now@:https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=50606

U.S. Opioid Withdrawal Treatment Market: Segmental Analysis

By Product Type
Medications
Therapies
Support Services

By Application
Detoxification
Rehabilitation
Palliative Care

By End User
Hospitals
Rehabilitation Centers
Homecare Settings

By Technology
Telehealth Solutions
Mobile Health Applications

By Distribution Channel
Pharmacies
Online Retail
Hospital Pharmacies

Countries Covered:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)

U.S. Opioid Withdrawal Treatment Market Opportunities and trends:
The U.S. opioid withdrawal treatment market is growing due to the persistent opioid crisis and increased awareness of medication-assisted treatments (MAT). Trends include the use of buprenorphine, methadone, and newer non-opioid medications like lofexidine. Telemedicine and digital therapeutics are enhancing treatment accessibility. Opportunities lie in integrated care models combining behavioral therapy and MAT, as well as expanding services through primary care and community health centers. Public funding, decriminalization efforts, and destigmatization of addiction treatment are further encouraging innovation and market growth.

Customization Service of the Report:
Exactitude Consultancy provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Click Here to Get a Sample Copy of the Latest Research on the U.S. Opioid Withdrawal Treatment Market in 2025 Before Purchase: https://exactitudeconsultancy.com/request-sample/50606

Table of Content: U.S. Opioid Withdrawal Treatment Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the U.S. Opioid Withdrawal Treatment market
Chapter 2: Exclusive Summary - the basic information of the U.S. Opioid Withdrawal Treatment Market
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the U.S. Opioid Withdrawal Treatment Market
Chapter 4: Presenting the U.S. Opioid Withdrawal Treatment Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the U.S. Opioid Withdrawal Treatment market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2025-2034)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

finally, U.S. Opioid Withdrawal Treatment Market is a valuable source of guidance for individuals and companies.

Discover More: Visit Our Website For Additional Reports!

https://www.minnesotabusinessreporter.com/article/737150514-global-medical-plastics-market-to-grow-from-usd-44-87-billion-in-2023-to-usd-78-93-billion-by-2031-with-a-cagr-of-6-9-exactitude-consultancy

https://www.openpr.com/news/3973651/ion-chromatography-market-new-product-development-latest#:~:text=Market%20Overview%3A,it%20indispensable%20for%20regulatory%20compliance.

https://www.openpr.com/news/3971831/u-s-synthetic-biology-market-emerging-trends-and-growth

https://www.openpr.com/news/3900691/yeastless-dough-market-is-set-to-experience-a-revolutionary

https://www.stvincentgenadinesbusinesshub.com/article/729798881-healthcare-it-integration-market-is-expected-to-reach-above-usd-11-42-billion-by-2030-exactitude-consultancy

https://pr.millismedwaynews.com/article/Vinyl-Record-Market-is-expected-to-be-valued-at-USD-542-billion-by-2033-or-Exactitude-Consultancy?storyId=66a78069709b0518e4b1751d

https://www.montserratbusinessnetwork.com/article/731583310-multirotor-drones-market-is-expected-to-be-valued-at-usd-10-15-billion-by-2029-exactitude-consultancy

https://www.latinamericabusinesstoday.com/article/733380032-toluene-market-is-expected-to-be-valued-at-usd-66-27-billion-by-2033-exactitude-consultancy

https://www.appliedtechnologynews.com/article/734870833-semiconductor-electrostatic-chuck-market-is-expected-to-be-valued-at-usd-1573-31-million-by-2032-exactitude-consultancy

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Opioid Withdrawal Treatment Market Emerging Trends and Growth Prospects 2034 |Indivior PLC,Alkermes plc,Teva Pharmaceutical Industries Ltd. here

News-ID: 3981479 • Views:

More Releases from Exactitude Consultancy

Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at 8.1% CAGR
Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at …
Introduction Hypertrophic cardiomyopathy (HCM) is a genetic heart disorder characterized by abnormal thickening of the heart muscle, which can impair blood flow and increase the risk of arrhythmias, heart failure, and sudden cardiac death. Once managed primarily through beta-blockers, calcium channel blockers, and invasive procedures, the HCM treatment landscape has expanded with the approval of targeted therapies such as cardiac myosin inhibitors. Growing awareness of genetic cardiovascular diseases, advances in molecular diagnostics,
Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion by 2034, Growing at 10.3% CAGR
Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion …
Introduction Biologics-including monoclonal antibodies, vaccines, recombinant proteins, and advanced therapies-are at the forefront of modern medicine. Their development, however, requires significant expertise, advanced infrastructure, and compliance with stringent regulatory standards. To meet these demands, pharmaceutical and biotechnology companies are increasingly outsourcing to Contract Research Organizations (CROs) specializing in biologics. Biologics CROs provide services spanning discovery, preclinical research, clinical trials, bioanalytical testing, and regulatory consulting. With the rise of biologics, biosimilars, and advanced
Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% CAGR
Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% …
Introduction Niemann-Pick disease (NPD) is a group of rare, inherited lysosomal storage disorders caused by mutations that disrupt lipid metabolism, leading to progressive neurological decline, organ dysfunction, and premature death. The condition is categorized into several subtypes (A, B, and C), each varying in severity and progression. Historically, treatment has been limited to palliative and supportive care. However, the landscape is changing rapidly with the development of enzyme replacement therapies (ERT), substrate
PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: Novartis AG & GSK
PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: N …
The fight against cancer and neurodegenerative diseases has brought the spotlight on the PERK (Protein kinase RNA-like endoplasmic reticulum kinase) pathway, a critical regulator of the unfolded protein response. PERK inhibitors are designed to modulate this pathway, reducing stress-induced cell death and playing a pivotal role in oncology, neurodegenerative research, and metabolic disorders. As precision medicine continues to gain traction, PERK inhibitors are attracting significant attention from both biotech firms

All 5 Releases


More Releases for Opioid

Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Opioid-Induced Constipation Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for treatment of opioid-induced constipation has seen a substantial growth recently. It is expected to escalate from a solid $1.78 billion in 2024 to an impressive $1.9 billion in 2025, exhibiting
Growing Number Of Opioid Addiction Cases: Strategic Insights Driving Opioid Use …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Opioid Use Disorder (OUD) Market Size By 2025? The market size for opioid use disorder (OUD) has experienced a quick expansion in the past few years. The growth is projected to rise from $3.96 billion in 2024 to $4.39 billion in 2025, boasting a compound
Key Influencer in the Opioid-Induced Constipation Treatment Market 2025: Rising …
What combination of drivers is leading to accelerated growth in the opioid-induced constipation treatment market? The rise in opioid administration for cancer and non-cancer pain is expected to drive the growth of the opioid-induced constipation (OIC) treatment market. Opioids are commonly used for managing moderate to severe pain, but they can cause constipation. OIC treatments are vital for improving the quality of life for patients on opioids, allowing them to maintain
Top Factor Driving Opioid Use Disorder (OUD) Market Growth in 2025: Growing Numb …
How Are the key drivers contributing to the expansion of the opioid use disorder (oud) market? The rise in instances of opioid dependency is set to fuel the expansion of the opioid use disorder (OUD) market. Opioid dependency defines a health concern marked by habitual and uncontrolled opioid consumption which negatively impacts health. These opioids can generate feelings of bliss and relief from pain, but continued usage often results in tolerance
What's Driving the Opioid-Induced Constipation Treatment Market 2025-2034: Risin …
What Are the Projections for the Size and Growth Rate of the Opioid-Induced Constipation Treatment Market? The market size for treatments of constipation caused by opioids has seen robust growth lately. The forecasted growth indicates an increase from $1.78 billion in 2024 to $1.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%. This past growth is associated with a growing elderly population, individualized treatments for OIC, the
MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana. Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622 Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal